vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and Home Federal Bancorp, Inc. of Louisiana (HFBL). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $6.0M, roughly 1.6× Home Federal Bancorp, Inc. of Louisiana). Home Federal Bancorp, Inc. of Louisiana runs the higher net margin — 27.8% vs -265.9%, a 293.7% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 18.2%).

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Home Federal Bancorp, Inc. of Louisiana is a U.S. bank holding company based in Louisiana. It operates community banking services via its subsidiary, offering retail customers and local small businesses a full suite of financial products including deposit accounts, consumer loans, mortgage loans, and commercial financing, primarily serving local markets across Louisiana.

CLLS vs HFBL — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.6× larger
CLLS
$9.5M
$6.0M
HFBL
Growing faster (revenue YoY)
CLLS
CLLS
+356.7% gap
CLLS
375.0%
18.2%
HFBL
Higher net margin
HFBL
HFBL
293.7% more per $
HFBL
27.8%
-265.9%
CLLS

Income Statement — Q2 FY2024 vs Q2 FY2026

Metric
CLLS
CLLS
HFBL
HFBL
Revenue
$9.5M
$6.0M
Net Profit
$-25.3M
$1.7M
Gross Margin
Operating Margin
-181.1%
35.1%
Net Margin
-265.9%
27.8%
Revenue YoY
375.0%
18.2%
Net Profit YoY
-51.9%
64.2%
EPS (diluted)
$-0.28
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
HFBL
HFBL
Q4 25
$6.0M
Q3 25
$5.9M
Q2 25
$5.6M
Q1 25
$5.2M
Q4 24
$5.1M
Q3 24
$4.7M
Q2 24
$9.5M
$4.9M
Q1 24
$4.9M
Net Profit
CLLS
CLLS
HFBL
HFBL
Q4 25
$1.7M
Q3 25
$1.6M
Q2 25
$1.2M
Q1 25
$748.0K
Q4 24
$1.0M
Q3 24
$941.0K
Q2 24
$-25.3M
$638.0K
Q1 24
$732.0K
Operating Margin
CLLS
CLLS
HFBL
HFBL
Q4 25
35.1%
Q3 25
34.1%
Q2 25
27.5%
Q1 25
18.3%
Q4 24
23.7%
Q3 24
19.9%
Q2 24
-181.1%
16.9%
Q1 24
18.5%
Net Margin
CLLS
CLLS
HFBL
HFBL
Q4 25
27.8%
Q3 25
27.1%
Q2 25
20.9%
Q1 25
14.4%
Q4 24
20.0%
Q3 24
19.9%
Q2 24
-265.9%
13.1%
Q1 24
14.9%
EPS (diluted)
CLLS
CLLS
HFBL
HFBL
Q4 25
$0.54
Q3 25
$0.52
Q2 25
$0.38
Q1 25
$0.24
Q4 24
$0.33
Q3 24
$0.31
Q2 24
$-0.28
$0.21
Q1 24
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
HFBL
HFBL
Cash + ST InvestmentsLiquidity on hand
$149.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
$57.7M
Total Assets
$407.1M
$621.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
HFBL
HFBL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$149.0M
Q1 24
Stockholders' Equity
CLLS
CLLS
HFBL
HFBL
Q4 25
$57.7M
Q3 25
$56.6M
Q2 25
$55.2M
Q1 25
$54.7M
Q4 24
$53.9M
Q3 24
$54.3M
Q2 24
$148.6M
$52.8M
Q1 24
$52.5M
Total Assets
CLLS
CLLS
HFBL
HFBL
Q4 25
$621.4M
Q3 25
$622.6M
Q2 25
$609.5M
Q1 25
$619.6M
Q4 24
$607.8M
Q3 24
$628.4M
Q2 24
$407.1M
$637.5M
Q1 24
$643.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
HFBL
HFBL
Operating Cash FlowLast quarter
$28.9M
$2.9M
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
HFBL
HFBL
Q4 25
$2.9M
Q3 25
$2.8M
Q2 25
$5.5M
Q1 25
$991.0K
Q4 24
$2.6M
Q3 24
$871.0K
Q2 24
$28.9M
$2.3M
Q1 24
$650.0K
Free Cash Flow
CLLS
CLLS
HFBL
HFBL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$843.0K
Q2 24
$27.6M
$2.3M
Q1 24
FCF Margin
CLLS
CLLS
HFBL
HFBL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
17.8%
Q2 24
290.5%
46.8%
Q1 24
Capex Intensity
CLLS
CLLS
HFBL
HFBL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.6%
Q2 24
13.2%
0.8%
Q1 24
Cash Conversion
CLLS
CLLS
HFBL
HFBL
Q4 25
1.70×
Q3 25
1.74×
Q2 25
4.64×
Q1 25
1.32×
Q4 24
2.54×
Q3 24
0.93×
Q2 24
3.63×
Q1 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons